Expand / Collapse search
Watch TV
Menu

This material may not be published, broadcast, rewritten, or redistributed. ©2024 FOX News Network, LLC. All rights reserved. Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. Mutual Fund and ETF data provided by Refinitiv Lipper.

Coronavirus

CDC panel meeting on COVID-19 vaccines, rare heart issues postponed in observance of Juneteenth

The CDC said the discussion will now be included in the scheduled June 23-25 ACIP meeting

By Alexandria Hein Fox News
Published
close
Possible link between COVID vaccine, heart inflammation in some teens Video

Possible link between COVID vaccine, heart inflammation in some teens

Fox News medical contributor Dr. Marc Siegel discusses new concerns over a possible link between the COVID vaccine and heart inflammation in teen males.

Friday’s scheduled CDC panel discussion on reports of heart inflammation among a small fraction of COVID-19 vaccine recipients has been postponed in observance of the Juneteenth National Independence Day holiday, the agency said. 

In an update posted to the CDC website, the agency said the discussion will now be included in the scheduled June 23-25 Advisory Committee on Immunization Practices (ACIP) meeting. 

"The June 18, 2021 COVID-19 meeting is being rescheduled due to the observation of the Juneteenth National Independence Day holiday," the webcast update said. "The discussion will be rescheduled to be included as part of the June 23-25 ACIP meeting." 

CDC PANEL TO DISCUSS COVID-19 VACCINATION, RARE HEART ISSUES

The ACIP was set to discuss about 300 reports of myocarditis and pericarditis predominately among vaccinated males aged 16-24. About 12 million doses of the vaccines have been administered, and while younger groups only account for about 9% of those shots, they comprised over half of 528 reports relating to heart issues across all age groups. 

The ACIP was not expected to vote on anything regarding the vaccine rollout but was set to provide an update on COVID-19 vaccine safety, including myocarditis after mRNA vaccines and the risk-benefit of mRNA vaccines in adolescents and young adults. The panel was also set to discuss an "overview of data to inform recommendations for additional doses of COVID-19 vaccines." 

CLICK HERE FOR COMPLETE CORONAVIRUS COVERAGE

The already scheduled June 23-25 meeting will include discussions on several vaccines including the influenza vaccine, pneumococcal vaccines, hepatitis vaccine, cholera vaccines and tickborne vaccines. It was unclear which date will include discussions on mRNA vaccines and reports of heart issues.